ID - 140
LONG-TERM OUTCOMES, SURVIVAL PREDICTORS AND UP-FRONT TREATMENT PATTERNS IN 568 ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS FROM LATAM: IS R-CHOP STILL THE FIRST CHOICE FOR TREATING PATIENTS OLDER THAN 60 YEARS?
RN de Vita, COO Reichert, HF Culler, ROd Costa, SAC Siqueira, IC Soares, V Rocha, J Pereira, LAPC Lage
Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo, SP, Brasil
